NCT00783081 - Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication | Biotech Hunter

Enrollment

387

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Intermittent Claudication

Interventions

DRUG

K-134

K-134 is given as low dose mid dose and high dose tablets for 26 Weeks.

DRUG

Cilostazol 100 mg BID

Cilostazol 100mg BID for 26 weeks.

DRUG

Placebo

Placebo BID for 26 weeks.

Trial Locations (42)

Unknown

Tucson

Little Rock

Beverly Hills

Los Angeles

Sacramento

Santa Rosa

Vista

Aurora

Clearwater

Gulf Breeze

Hialeah

Jacksonville

Pensacola

Sarasota

St. Petersburg

Aurora

Chicago

Hinsdale

Indianapolis

Auburn

St Louis

Oklahoma City

Danville

Warwick

Charleston

Amarillo

Houston

Norfolk

Richmond

Madison

Gatchina

Irkutsk

Moscow

Novosibirsk

Pskov

Saint Petersburg

Saratov

Smolensk

Sochi

Tomsk

Volgograd

Yaroslavl